Medical

Pathways Neuro Pharma Targets Rare Pediatric Neurological Disorders with Pioneering Gene Therapy

WEST CHESTER, PA — Pathways Neuro Pharma Inc. has announced a significant pivot in its development pipeline, prioritizing rare pediatric neurological disorders, with Juvenile Parkinson’s Disease (JPD) leading the charge. This …

Pathways Neuro Pharma Targets Rare Pediatric Neurological Disorders with Pioneering Gene Therapy Read More


U.S. Food and Drug Administration (FDA)

FDA Takes Action on Allergies, Diabetes, Parkinson’s, and Deadly Food Safety Scare—What You Need to Know

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced several significant developments this week, spanning advancements in allergy treatment, diabetes management, and Parkinson’s disease therapy, as well …

FDA Takes Action on Allergies, Diabetes, Parkinson’s, and Deadly Food Safety Scare—What You Need to Know Read More